Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Chugai Pharmaceutical Co., Ltd.

Market Cap 12,426B 77.05B 67.18B 62.22B 58.24B 109B 7,270B 110B 738B 286B 3,579B 289B 283B P/E 2026 *
24.3x
P/E 2027 * 20.9x
Enterprise Value 11,503B 71.33B 62.19B 57.6B 53.92B 101B 6,730B 102B 683B 265B 3,313B 268B 262B EV / Sales 2026 *
8.29x
EV / Sales 2027 * 7.33x
Free-Float
38.12%
Yield 2026 *
1.81%
Yield 2027 * 2.08%
1 day-0.21%
1 week+1.34%
Current month-4.33%
1 month-4.42%
3 months-12.72%
6 months-8.94%
Current year-8.41%
1 week 7,376
Extreme 7376
7,719
1 month 7,270
Extreme 7270
8,215
Current year 7,270
Extreme 7270
10,700
1 year 5,942
Extreme 5942
10,700
3 years 3,767
Extreme 3767
10,700
5 years 3,191
Extreme 3191
10,700
10 years 1,003.33
Extreme 1003.3333
10,700
Manager TitleAgeSince
Chief Executive Officer 63 2020-12-31
Director of Finance/CFO - 2024-03-27
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 1993-02-28
Director/Board Member 81 2015-02-28
Director/Board Member 77 2017-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%+1.34%+5.02%+75.58% 77.05B
-1.21%-3.04%+44.03%+143.07% 980B
-2.48%-5.18%+52.47%+39.15% 550B
-2.14%-4.94%+16.83%+57.08% 382B
+0.25%-3.09%+23.33%+16.04% 316B
+0.61%-1.69%+27.35%+13.73% 272B
+0.22%-3.10%+24.67%+30.49% 268B
+4.59%+1.98%-38.43%-46.26% 199B
-1.19%-4.95%+16.68%+47.69% 182B
-1.35%-1.46%+14.06%+59.26% 154B
Average -0.29%-2.58%+18.60%+43.58% 337.94B
Weighted average by Cap. -0.77%-3.56%+28.93%+63.59%

Financials

2026 *2027 *
Net sales 1,387B 8.6B 7.5B 6.95B 6.5B 12.19B 812B 12.27B 82.39B 31.93B 399B 32.28B 31.59B 1,535B 9.52B 8.3B 7.69B 7.2B 13.5B 898B 13.58B 91.19B 35.34B 442B 35.73B 34.97B
Net income 511B 3.17B 2.76B 2.56B 2.39B 4.49B 299B 4.52B 30.33B 11.76B 147B 11.89B 11.63B 593B 3.68B 3.21B 2.97B 2.78B 5.21B 347B 5.25B 35.24B 13.66B 171B 13.81B 13.51B
Net Debt -923B -5.72B -4.99B -4.62B -4.32B -8.11B -540B -8.16B -54.8B -21.24B -266B -21.47B -21.01B -1,166B -7.23B -6.3B -5.84B -5.46B -10.25B -682B -10.31B -69.25B -26.84B -336B -27.13B -26.55B
Logo Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.
Employees
5,104
Date Price Change Volume
26-06-19 7,550.00 ¥ -0.21% 3,697,700
26-06-18 7,566.00 ¥ -1.10% 1,954,000
26-06-17 7,650.00 ¥ +1.69% 1,745,000
26-06-16 7,523.00 ¥ +1.28% 2,083,200
26-06-15 7,428.00 ¥ -0.30% 1,824,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
7,550.00JPY
Average target price
9,973.33JPY
Spread / Average Target
+32.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4519 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!